Study summary · research use only
Methylene Blue in Refractory Shock
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This case report and brief literature review discusses the use of methylene blue in a human patient with refractory shock in an intensive care unit (ICU), a setting where the abstract notes many patients experience shock and most respond to standard vasopressor treatment along with treatment of the underlying cause. The authors note methylene blue has been used in some patients who do not respond to vasopressors, describing this use as having had some success in the past, and present a case report on its use along with a brief literature review.
Abstract
Many patients suffer shock in intensive care units (ICU). The majority of the patients with shock respond to standard treatment with vasopressors in addition to the treatment of underlying etiology. Some may not respond to vasopressors and have high mortality. To those patients who do not respond, methylene blue has been used in the past with some success. We present a case report on the use of methylene blue along with a brief literature review.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.